Sacroiliac Joint Fusion Market Size, Share & Trends Report

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68039-805-9
  • Number of Pages: 162
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Sacroiliac Joint Fusion Indication Outlook (Revenue, USD Million, 2018 - 2030)
    • Degenerative sacroiliitis
    • Sacral disruption
    • Trauma
  • Sacroiliac Joint Fusion Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Surgery
      • By Surgery Type
        • MIS
        • MIS
      • By Approach
        • Dorsal
        • Anterior
      • By Product
        • Implants
        • Accessories
    • Injections
      • Diagnosis
      • Treatment
    • RF Ablation
  • Sacroiliac Joint Fusion End User Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Ambulatory surgical centers
    • Others (Specialty Centers, Research & Academic Institutes)
  • Sacroiliac Joint Fusion Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Degenerative sacroiliitis
        • Sacral disruption
        • Trauma
      • North America Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
        • Surgery
          • By Surgery Type
            • MIS
            • MIS
          • By Approach
            • Dorsal
            • Anterior
          • By Product
            • Implants
            • Accessories
        • Injections
          • Diagnosis
          • Treatment
        • RF Ablation
      • North America End User Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Ambulatory surgical centers
        • Others (Specialty Centers, Research & Academic Institutes)
      • U.S.
        • U.S. Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • U.S. Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • U.S. End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Canada
        • Canada Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Canada Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Canada End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
    • Europe
      • Europe Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Degenerative sacroiliitis
        • Sacral disruption
        • Trauma
      • Europe Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
        • Surgery
          • By Surgery Type
            • MIS
            • MIS
          • By Approach
            • Dorsal
            • Anterior
          • By Product
            • Implants
            • Accessories
        • Injections
          • Diagnosis
          • Treatment
        • RF Ablation
      • Europe End User Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Ambulatory surgical centers
        • Others (Specialty Centers, Research & Academic Institutes)
      • U.K.
        • U.K. Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • U.K. Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • U.K. End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Germany
        • Germany Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Germany Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Germany End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • France
        • France Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • France Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • France End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Italy
        • Italy Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Italy Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Italy End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Spain
        • Spain Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Spain Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Spain End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Denmark
        • Denmark Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Denmark Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Denmark End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Sweden
        • Sweden Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Sweden Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Sweden End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Norway
        • Norway Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Norway Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Norway End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
    • Asia Pacific
      • Asia Pacific Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Degenerative sacroiliitis
        • Sacral disruption
        • Trauma
      • Asia Pacific Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
        • Surgery
          • By Surgery Type
            • MIS
            • MIS
          • By Approach
            • Dorsal
            • Anterior
          • By Product
            • Implants
            • Accessories
        • Injections
          • Diagnosis
          • Treatment
        • RF Ablation
      • Asia Pacific End User Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Ambulatory surgical centers
        • Others (Specialty Centers, Research & Academic Institutes)
      • China
        • China Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • China Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • China End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Japan
        • Japan Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Japan Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Japan End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • India
        • India Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • India Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • India End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Australia
        • Australia Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Australia Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Australia End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Thailand
        • Thailand Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Thailand Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Thailand End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • South Korea
        • South Korea Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • South Korea Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • South Korea End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
    • Latin America
      • Latin America Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Degenerative sacroiliitis
        • Sacral disruption
        • Trauma
      • Latin America Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
        • Surgery
          • By Surgery Type
            • MIS
            • MIS
          • By Approach
            • Dorsal
            • Anterior
          • By Product
            • Implants
            • Accessories
        • Injections
          • Diagnosis
          • Treatment
        • RF Ablation
      • Latin America End User Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Ambulatory surgical centers
        • Others (Specialty Centers, Research & Academic Institutes)
      • Brazil
        • Brazil Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Brazil Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Brazil End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Mexico
        • Mexico Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Mexico Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Mexico End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Argentina
        • Argentina Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Argentina Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Argentina End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
    • Middle East & Africa
      • Middle East & Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
        • Degenerative sacroiliitis
        • Sacral disruption
        • Trauma
      • Middle East & Africa Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
        • Surgery
          • By Surgery Type
            • MIS
            • MIS
          • By Approach
            • Dorsal
            • Anterior
          • By Product
            • Implants
            • Accessories
        • Injections
          • Diagnosis
          • Treatment
        • RF Ablation
      • Middle East & Africa End User Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Ambulatory surgical centers
        • Others (Specialty Centers, Research & Academic Institutes)
      • South Africa
        • South Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • South Africa Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • South Africa End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Saudi Arabia
        • Saudi Arabia Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Saudi Arabia Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Saudi Arabia End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • UAE
        • UAE Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • UAE Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • UAE End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)
      • Kuwait
        • Kuwait Indication Outlook (Revenue, USD Million, 2018 - 2030)
          • Degenerative sacroiliitis
          • Sacral disruption
          • Trauma
        • Kuwait Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
          • Surgery
            • By Surgery Type
              • MIS
              • MIS
            • By Approach
              • Dorsal
              • Anterior
            • By Product
              • Implants
              • Accessories
          • Injections
            • Diagnosis
            • Treatment
          • RF Ablation
        • Kuwait End User Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Ambulatory surgical centers
          • Others (Specialty Centers, Research & Academic Institutes)

Sacroiliac Joint Fusion Market Dynamics

Driver: Increasing Prevalence Of Lower Back, Buttock, Groin, And Lower Extremity Pain

The increasing prevalence of buttock, groin, lower back, and lower edge pain is driving the SI joint fusion market growth. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, reported in December 2021, the Centers for Medicare & Medicaid Services. The increasing prevalence of Lower Back Pain (LBP), with a projected 843 million cases by 2050, emphasizes the magnitude of this healthcare issue. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels the demand for innovative solutions to alleviate suffering and restore mobility.The surging prevalence of LBP across the globe is propelling the SI joint fusion market growth. Similarly, the rising prevalence of buttock and groin pain increases the likelihood of SI joint disorders, improving market growth.

Driver: Technological Advancements

Technological advancements are revolutionizing healthcare sector, and the SI joint fusion market is no exception. Growing demand for advanced technology in the healthcare sector is expected to fuel market progress. Another factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. This includes the use of additive manufacturing and 3D-printed titanium implants.

Restraint: Lack Of Awareness Regarding Sacroiliac Joint Fusion Procedure

Lack of awareness can lead to slower sacroiliac joint fusion market growth, especially in developing and underdeveloped economies. Several people in these regions suffer from sacroiliac joint disorders; however, very few seek medical help. This is because many people are unaware of this medical condition, resulting in worsening pain. The lack of awareness is associated with inaccessibility to healthcare organizations or inadequate information. This results in fear of taking preventive treatment.

What Does This Report Include?

This section will provide insights into the contents included in this sacroiliac joint fusion market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Sacroiliac joint fusion market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Sacroiliac joint fusion market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon